tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
OTHER OTC:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Income Statement

Compare
571 Followers

Brainstorm Cell Therapeutics Income Statement

Last quarter (Q3 2025), Brainstorm Cell Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Brainstorm Cell Therapeutics's net income was $-2.11M. See Brainstorm Cell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 849.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 849.00K$ -265.00K$ -285.00K$ -260.00K$ -219.00K
Operating Expenses
$ 11.45M$ 21.17M$ 24.82M$ 24.54M$ 31.68M
Depreciation and Amortization
$ 240.00K$ 265.00K$ 285.00K$ 260.00K$ 219.00K
EBITDA
$ -11.31M$ -16.93M$ -23.99M$ -24.28M$ -31.46M
Operating Income
$ -11.69M$ -21.44M$ -24.82M$ -24.54M$ -31.68M
Other Income/Expenses
$ 70.00K$ 4.25M$ 545.00K$ 82.00K$ -127.00K
Pretax Income
$ 11.62M$ -17.19M$ -24.28M$ -24.46M$ -31.81M
Net Income
$ 11.62M$ -17.19M$ -24.28M$ -24.46M$ -31.81M
Per Share Metrics
Basic EPS
$ 2.19$ -4.48$ -9.93$ -10.09$ -14.09
Diluted EPS
$ 2.19$ -4.48$ -9.93$ -10.09$ -14.09
Weighted Average Shares Outstanding
5.31M 3.84M 2.45M 2.42M 2.26M
Weighted Average Shares Outstanding (Diluted)
5.31M 3.84M 2.45M 2.42M 2.26M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History